Affinity Asset Advisors, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001773195

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q2 2024 · 90 positions · Total reported value $781.33M · Top-10 concentration 52.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.3% · 24 new · 29 cut · 20 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -12.1% · vs SPY -14.3% · Prev Value $2.08B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.2% · vs SPY -4.3% · Latest Value $2.15B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, Affinity Asset Advisors, LLC disclosed 90 equity positions with a combined reported value of $781.33M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 52.9% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were SPY ($190.48M), XENE ($38.76M), APGE ($32.91M). By sector, the heaviest allocations are Health Care 49.8%, Materials 0.2%. Versus the prior quarter, allocation shifted toward Other (+9.3pp) and away from Health Care (-9.3pp).

Versus the prior quarter, Affinity Asset Advisors, LLC opened 24 new positions, trimmed 29 and fully exited 20, a turnover rate of 55.3% of positions. The portfolio's overlap with the prior quarter was 55% of names.

The largest new positions opened in Q2 2024 were SPY ($190.48M), CLYM ($11.88M), MRUS ($7.40M).

Of the 20 positions fully exited versus the prior quarter, the largest were MRNA ($42.62M), APLS ($9.70M), IRWD ($8.97M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • SPY STATE STR SPDR S&P 500 ETF T · $190.48M
  • CLYM CLIMB BIO INC · $11.88M
  • MRUS MERUS N V · $7.40M
  • KPTI KARYOPHARM THERAPEUTICS INC · $6.30M
  • ERAS ERASCA INC · $5.90M
  • HLVX HILLEVAX INC · $3.84M
  • DYN DYNE THERAPEUTICS INC · $3.53M
  • PCSC PERCEPTIVE CAP SOLUTIONS COR · $3.52M

Fully Exited (vs previous quarter)

  • MRNA MODERNA INC · prev qtr: $42.62M · history
  • APLS APELLIS PHARMACEUTICALS INC · prev qtr: $9.70M
  • IRWD IRONWOOD PHARMACEUTICALS INC · prev qtr: $8.97M
  • GRTSQ GRITSTONE BIO INC · prev qtr: $6.14M
  • ABSI ABSCI CORPORATION · prev qtr: $5.82M
  • CYTK CYTOKINETICS INC · prev qtr: $5.61M · history
  • GH GUARDANT HEALTH INC · prev qtr: $5.16M
  • KRYS KRYSTAL BIOTECH INC · prev qtr: $4.76M

Insider Transactions (Form 4)

Latest Affinity Asset Advisors, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Affinity Asset Advisors, LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 108 US equity positions with a combined value of $2.08B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-120744 (status: Approved), registered 2021-04-09
  • Regulatory AUM (Form ADV): $2.45B as of 2026-07-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds
  • Website: affinityadv.com

Portfolio Structure

  • 108 positions · $2.08B reported value (Q2 2026)
  • Top 10 holdings = 41.7% of reported value
  • Largest position: ROIV (ROIVANT SCIENCES LTD) at 6.4%
  • Average position size: $19.25M

Sector Tilt

  • Health Care 87.6%
  • Financials 1.3%
  • Materials 0.3%
  • (classified holdings cover 89% of value)

Quarterly Activity

  • Q2 2026: 19 new, 34 added, 31 reduced, 12 exited
  • 24 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 49.8%
Materials 0.2%
Other 49.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 350.00K $190.48M 24.38%
24.38%
New
2 994.23K $38.76M 4.96%
4.96%
Add
3 836.28K $32.91M 4.21%
4.21%
Add
4 110.00K $30.82M 3.94%
3.94%
Reduce
5 460.00K $25.39M 3.25%
3.25%
Add
6 515.00K $23.07M 2.95%
2.95%
Add
7 912.00K $19.03M 2.44%
2.44%
Add
8 1.15M $18.69M 2.39%
2.39%
Reduce
9 475.40K $17.59M 2.25%
2.25%
Reduce
10 15.00M $16.20M 2.07%
2.07%
Add
11 110.00K $15.69M 2.01%
2.01%
Add
12 650.00K $15.66M 2.00%
2.00%
Add
13 200.00K $15.17M 1.94%
1.94%
Add
14 4.30M $14.96M 1.92%
1.92%
Add
15 375.00K $13.57M 1.74%
1.74%
Reduce
16 650.00K $13.38M 1.71%
1.71%
Reduce
17 2.86M $12.74M 1.63%
1.63%
Add
18 513.42K $12.07M 1.54%
1.54%
Add
19 1.67M $11.88M 1.52%
1.52%
New
20 1.14M $10.26M 1.31%
1.31%
Add
21 250.00K $10.22M 1.31%
1.31%
Reduce
22 223.41K $10.15M 1.30%
1.30%
Add
23 700.00K $10.12M 1.29%
1.29%
Reduce
24 200.00K $9.63M 1.23%
1.23%
Add
25 975.61K $8.88M 1.14%
1.14%
Add
26 11.75M $8.64M 1.10%
1.10%
Add
27 250.57K $8.54M 1.09%
1.09%
Add
28 423.15K $8.13M 1.04%
1.04%
Add
29 11.45M $8.08M 1.03%
1.03%
Add
30 1.85M $7.96M 1.02%
1.02%
Add
31 125.00K $7.40M 0.95%
0.95%
New
32 80.00K $6.44M 0.82%
0.82%
Reduce
33 1.50M $6.36M 0.81%
0.81%
Reduce
34 9.75M $6.30M 0.81%
0.81%
New
35 1.55M $6.23M 0.80%
0.80%
Add
36 2.50M $5.90M 0.76%
0.76%
New
37 550.00K $5.48M 0.70%
0.70%
Reduce
38 155.00K $5.30M 0.68%
0.68%
Reduce
39 263.82K $4.60M 0.59%
0.59%
Add
40 1.47M $3.97M 0.51%
0.51%
Add
41 265.86K $3.84M 0.49%
0.49%
New
42 327.96K $3.84M 0.49%
0.49%
Hold
43 351.59K $3.72M 0.48%
0.48%
Reduce
44 100.00K $3.53M 0.45%
0.45%
New
45 350.00K $3.52M 0.45%
0.45%
New
46 300.00K $3.49M 0.45%
0.45%
Reduce
47 37.55K $3.48M 0.45%
0.45%
Reduce
48 1.62M $3.25M 0.41%
0.41%
Add
49 650.00K $3.03M 0.39%
0.39%
New
50 500.51K $3.02M 0.39%
0.39%
Reduce

FAQ

What did Affinity Asset Advisors, LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, Affinity Asset Advisors, LLC reported 90 equity positions worth $781.33M in aggregate; its largest disclosed positions were SPY ($190.48M), XENE ($38.76M), APGE ($32.91M).

How large is Affinity Asset Advisors, LLC's portfolio?

Affinity Asset Advisors, LLC reported $781.33M of long equity holdings across 90 positions as of 2024-Q2. Top-10 holdings account for 52.9% of reported value.

What is Affinity Asset Advisors, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/affinity-asset-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →